Clinical features POEMS patients—three series.
. | Mayo Series3 . | French Series1 . | Japanese Series2 . |
---|---|---|---|
. | %n=99 . | %n=25 . | %n=102 . |
Abbreviations: NS, not stated | |||
Comment: The percentage for all series uses the total number of patients in the series as the denominator | |||
*Includes gonadal and adrenal abnormalities | |||
**Of patients with bone lesions | |||
This table was modified froma table originally published in Blood. Dispenzieri et al. POEMS syndrome: definitions and long-term outcome. Blood . 2003 ;101 :2496 –2506 | |||
Peripheral neuropathy | 100 | 100 | 100 |
Organomegaly | 46 | NS | NS |
Hepatomegaly | 25 | 68 | 78 |
Splenomegaly | 22 | 52 | 35 |
Lymphadenopathy | 26 | 52 | 61 |
Endocrinopathy | 71* | NS | NS |
Diabetes | 3 | 36 | 25 |
Hypothyroidism | 17 | 36 | |
Monoclonal plasma cell dyscrasia | 100 | 100 | 75 |
Skin Changes | 68 | NS | NS |
Hyperpigmentation | 46 | 48 | 93 |
Acrocyanosis and plethora | 19 | NS | NS |
Hemangioma/telangectasia | 9 | 32 | NS |
Hypertrichosis | 26 | 24 | 74 |
Thickening | 5 | 28 | 61 |
Sclerotic bone lesions | 97 | 68 | 54 |
Osteosclerotic only** | 47 | 41 | 56 |
Mixed sclerotic and lytic** | 51 | 59 | 31 |
Lytic only** | 2 | 0 | 13 |
> 1 lesion** | 54 | 59 | 45 |
Papilledema | 29 | 40 | 55 |
Extravascular volume overload | 39 | NS | NS |
Peripheral edema | 29 | 80 | 89 |
Ascites | 15 | 32 | 52 |
Pleural effusion | 9 | 24 | 35 |
Castleman disease | 11 | 24 | 19 |
Other features | |||
Thrombocytosis | 54 | 88 | NS |
Polycythemia | 18 | 12 | 19 |
Clubbing | 5 | 32 | 49 |
. | Mayo Series3 . | French Series1 . | Japanese Series2 . |
---|---|---|---|
. | %n=99 . | %n=25 . | %n=102 . |
Abbreviations: NS, not stated | |||
Comment: The percentage for all series uses the total number of patients in the series as the denominator | |||
*Includes gonadal and adrenal abnormalities | |||
**Of patients with bone lesions | |||
This table was modified froma table originally published in Blood. Dispenzieri et al. POEMS syndrome: definitions and long-term outcome. Blood . 2003 ;101 :2496 –2506 | |||
Peripheral neuropathy | 100 | 100 | 100 |
Organomegaly | 46 | NS | NS |
Hepatomegaly | 25 | 68 | 78 |
Splenomegaly | 22 | 52 | 35 |
Lymphadenopathy | 26 | 52 | 61 |
Endocrinopathy | 71* | NS | NS |
Diabetes | 3 | 36 | 25 |
Hypothyroidism | 17 | 36 | |
Monoclonal plasma cell dyscrasia | 100 | 100 | 75 |
Skin Changes | 68 | NS | NS |
Hyperpigmentation | 46 | 48 | 93 |
Acrocyanosis and plethora | 19 | NS | NS |
Hemangioma/telangectasia | 9 | 32 | NS |
Hypertrichosis | 26 | 24 | 74 |
Thickening | 5 | 28 | 61 |
Sclerotic bone lesions | 97 | 68 | 54 |
Osteosclerotic only** | 47 | 41 | 56 |
Mixed sclerotic and lytic** | 51 | 59 | 31 |
Lytic only** | 2 | 0 | 13 |
> 1 lesion** | 54 | 59 | 45 |
Papilledema | 29 | 40 | 55 |
Extravascular volume overload | 39 | NS | NS |
Peripheral edema | 29 | 80 | 89 |
Ascites | 15 | 32 | 52 |
Pleural effusion | 9 | 24 | 35 |
Castleman disease | 11 | 24 | 19 |
Other features | |||
Thrombocytosis | 54 | 88 | NS |
Polycythemia | 18 | 12 | 19 |
Clubbing | 5 | 32 | 49 |